Mechanisms for mindfulness in migraine: Does catastrophizing matter?
Abstract
Many patients and providers are interested in non-pharmacological treatments for migraine. Mindfulness has emerged as an option with the potential for significant migraine therapeutic benefits. In a recent issue of Headache , Kruse and Seng presented their secondary analysis of mediators of improvement seen in headache-related disability from their randomized clinical trial of mindfulness-based cognitive therapy (MBCT) compared to a wait-list control group in adults with 6–30 migraine attacks/month ( n = 60). 1 The authors assessed the mediating impact of pain catastrophizing (ruminat-ing, magnifying
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 60 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.